Award
National Cancer Institute RFA-CA-23-029
Chimeric RNA driven neopeptide vaccine for prevention of breast cancer in germline BRCA1/2 carriers
Recipient
University of TX MD Anderson Cancer Center
Award Amount
$670,898.00
Ceiling
$670,898.00
Awarded
June 16, 2026
Identifier
RFA-CA-23-029
Grant awarded by the National Cancer Institute for developing a vaccine to prevent breast cancer in BRCA1/2 mutation carriers.
Description
A grant opportunity for research on a chimeric RNA-driven neopeptide vaccine aimed at preventing breast cancer in germline BRCA1/2 mutation carriers. The project involves genomics, bioinformatics, and immunology, with a focus on vaccine development and preclinical testing.